The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Perfusion Systems Global Market Report 2024, the perfusion systems market is expected to show promising growth in the forecast period.

Introduction to the Perfusion Systems Market

• Rapid growth witnessed in recent years
• Projected increase from $1.24 billion in 2023 to $1.36 billion in 2024, with a CAGR of 10.2%
• Foundational research, hypothermia techniques, and cardiopulmonary bypass contribute to historic growth

Anticipated Growth and Market Dynamics

• Expected surge to $1.96 billion by 2028, with a CAGR of 9.6%
• Focus on patient outcomes and rise in cardiovascular surgeries fuel growth
• Expansion of minimally invasive procedures and increased ECMO usage

Major Trends in the Forecast Period

• Portable and compact designs
• Automation and robotics integration
• Remote monitoring and telemedicine
• Modular and customizable platforms
• Advanced data analytics and AI implementation

Surge In Organ Transplants Fuels Growth In The Perfusion Systems Market

• Organ transplants drive demand for perfusion systems
• Perfusion systems crucial for preserving and transporting organs
• Rising number of organ transplants worldwide
• Key players include Getinge AB, Medtronic PLC, LivaNova PLC, and Terumo Corporation

View More On The Perfusion Systems Market Report 2024 – https://www.thebusinessresearchcompany.com/report/perfusion-systems-global-market-report

Livanova Unveils Essenz Perfusion System, Redefining Cardiac Surgery Standards

• Product innovation shapes the market landscape
• LivaNova launches the Essenz perfusion system in Europe
• Compact, modular, and portable cardiopulmonary bypass system
• Customizable to meet specific patient and procedural needs

Merck & Co Inc. Expands Upstream Portfolio Through Strategic Acquisition

• Merck & Co. Inc. acquires Erbi Biosystems Inc. to enhance its upstream portfolio
• Acquisition aimed at scalable cell-based perfusion bioreactor processes
• Strengthens Merck’s position in therapeutic proteins segment
• Erbi Biosystems Inc. contributes to innovation in biotechnology tools

Market Segmentation

1. By Product: Cardiopulmonary Perfusion System, ECMO, Isolated Organ Perfusion Systems, Others
2. By Type Of Organ: Heart, Lung, Kidney, Liver, Others
3. By Technique: Hypothermic, Normothermic
4. By End-User: Hospital, Clinic, Ambulatory Surgical Centers, Others

Regional Analysis

• North America leads the perfusion systems market
• Increasing adoption of advanced medical technologies in the region

Conclusion The perfusion systems market is witnessing significant growth driven by technological advancements, innovations in product design, and the increasing prevalence of cardiovascular surgeries and organ transplants. Companies are focusing on developing portable, customizable, and automated systems to meet the evolving needs of healthcare professionals and patients. With the rise in organ transplantation and the expansion of healthcare infrastructure globally, the perfusion systems market is poised for continued growth and innovation in the coming years. As major players invest in research and development, the market will continue to shape the future of cardiac surgery and organ transplantation, ultimately enhancing patient care and outcomes worldwide.

Request A Sample Of The Global Perfusion Systems Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=10718&type=smp